Physician profile
Mitchell L Bernstrom
NPI 1265489967
$546.62
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $426 · 2020: $107 · 2021: $13.73.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $91.81 | 2019-2020 | |
| Allergan, INC. | $80.57 | 2019-2020 | |
| Amgen INC. | $60.95 | 2019 | |
| Novo Nordisk INC | $50.64 | 2019 | |
| Sunovion Pharmaceuticals INC. | $37.51 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $35.24 | 2019 | |
| Novartis Pharmaceuticals Corporation | $33.22 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $28.27 | 2019-2020 | |
| Lilly USA, LLC | $24.40 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.95 | 2019 | |
| Amarin Pharma, INC. | $19.45 | 2020 | |
| Daiichi Sankyo INC. | $15.53 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.82 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $11.77 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.31 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $11.18 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Bernstrom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.